September 24, 2014—Pharmaceutical manufacturers’ current safeguards may not prevent all copayment coupons from being used for drugs paid for by Medicare Part D, the U.S. Health and Human Services Office of Inspector General says in a new report.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register.
Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)